ALCRESTA PHARMACEUTICALS
Dead / Abandoned — Abandoned — no statement of use filed (as of 27 Feb 2017)
What this means for you
This application is over — abandoned 27 Feb 2017. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86698948
- Mark type
- Stylized text
- Filed
- 20 Jul 2015
- Published for opposition
- 31 May 2016
- Abandoned
- 27 Feb 2017
- Attorney of record
- Perry J. Viscounty
Goods and services
- Class 005 — Pharmaceuticals: Medical nutritional formula, namely, formula for use as a nutritional supplement; infant formula; dietetic foods adapted for medical use; enzymes for medical purposes; dietary and nutritional supplements; pharmaceutical preparations for the treatment of nutritional, gastrointestinal, digestive, metabolic, urological, nephrology, endocrine, oncologic, rheumatologic, inflammatory, pediatric, elderly, immunologic, cardiovascular, dermatologic, hematologic, infectious, circulatory, surgery and would healing, mental illness, pulmonary, muscular and respiratory diseases and disorders
- Class 010 — Medical apparatus: Filtering device for processing and converting medical nutritional formula
Owner
- ALCRESTA THERAPEUTICS, INC., NEWTON, MA, US
- Alcresta, Inc., Newton, MA, US
- Alcresta, Inc., Newton, MA, US
Prosecution history
- 27 Feb 2017 — ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
- 27 Feb 2017 — ABANDONMENT - NO USE STATEMENT FILED
- 26 Jul 2016 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 06 Jul 2016 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 31 May 2016 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 31 May 2016 — PUBLISHED FOR OPPOSITION
- 11 May 2016 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 22 Apr 2016 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 21 Apr 2016 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 20 Apr 2016 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 20 Apr 2016 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 24 Oct 2015 — NOTIFICATION OF PRIORITY ACTION E-MAILED
- 24 Oct 2015 — PRIORITY ACTION E-MAILED
- 24 Oct 2015 — PRIORITY ACTION WRITTEN
- 22 Oct 2015 — ASSIGNED TO EXAMINER